Study Overview: This study tests if a Continuous Glucose Monitoring (CGM) system helps manage blood sugar better than fingersticks for people with type 2 diabetes (T2D) after leaving the hospital. The CGM system uses a sensor under the skin to track blood sugar and has alarms for high or low levels. Participants will wear CGM sensors for up to 14 days over three months. They will visit the study site four times and have two phone calls with researchers.
Comparison: Researchers will compare the CGM method to the fingerstick method. Half of the participants will use CGM, while the other half will use fingersticks. The aim is to see if CGM reduces the risk of low blood sugar more effectively.
- Duration: 12 weeks with sensor use for 12-14 days, three times.
- Visits: Four site visits and two phone calls.
- Eligibility: Adults (≥18 years) with T2D, not using CGM before.
How understandable was the trial content above?
Hard to understand
Easy to understand